Ionis Pharma (IONS) Announces Significant Data from IONIS-FXIRx Phase 2 in Patients w/ ESRD on Hemodialysis
Go back to Ionis Pharma (IONS) Announces Significant Data from IONIS-FXIRx Phase 2 in Patients w/ ESRD on Hemodialysis(NASDAQ: IONS) | Delayed: 42.45 +0.61 (1.46%) | |||||
---|---|---|---|---|---|---|
Previous Close | $41.84 | 52 Week High | $62.68 | |||
Open | $41.97 | 52 Week Low | $19.59 | |||
Day High | $42.72 | P/E | N/A | |||
Day Low | $41.59 | EPS | $0.00 | |||
Volume | 728,801 |